Proposed Data Collection Submitted for Public Comment and Recommendations, 14921-14923 [2021-05762]
Download as PDF
<![CDATA[
Federal Register / Vol. 86, No. 52 / Friday, March 19, 2021 / Notices
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2021–05766 Filed 3–18–21; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Solicitation of Nominations for
Appointment to the Healthcare
Infection Control Practices Advisory
Committee (HICPAC)
ACTION:
Notice.
The Centers for Disease
Control and Prevention (CDC) is seeking
nominations for membership on the
HICPAC. The HICPAC consists of 14
experts in fields including but not
limited to, infectious diseases, infection
prevention, healthcare epidemiology,
nursing, clinical microbiology, surgery,
hospitalist medicine, internal medicine,
epidemiology, health policy, health
services research, public health, and
related medical fields. Nominations are
being sought for individuals who have
expertise and qualifications necessary to
contribute to the accomplishments of
the committee’s objectives. Nominees
will be selected based on expertise in
the fields of infectious diseases,
infection prevention, healthcare
epidemiology, nursing, environmental
and clinical microbiology, surgery,
internal medicine, and public health.
Federal employees will not be
considered for membership. Members
may be invited to serve for four-year
terms. Selection of members is based on
candidates’ qualifications to contribute
to the accomplishment of HICPAC
objectives https://www.cdc.gov/hicpac/.
DATES: Nominations for membership on
the HICPAC must be received no later
than September 17, 2021. Packages
received after this time will not be
considered for the current membership
cycle.
ADDRESSES: All nominations should be
mailed to HICPAC, Division of
Healthcare Quality Promotion (DHQP),
National Center for Emerging Zoonotic
Infectious Diseases (NCEZID), CDC, l600
Clifton Road NE, Mailstop H16–3,
Atlanta, Georgia 30329–4027, emailed
(recommended) to hicpac@cdc.gov, or
faxed to (404) 639–4043.
FOR FURTHER INFORMATION CONTACT: KooWhang Chung, MPH, HICPAC, DHQP,
NCEZID, CDC, l600 Clifton Road, NE,
jbell on DSKJLSW7X2PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
19:13 Mar 18, 2021
Jkt 253001
14921
Mailstop H16–3, Atlanta, Georgia
30329–4027; hicpac@cdc.gov.
Prevention and the Agency for Toxic
Substances and Disease Registry.
The U.S.
Department of Health and Human
Services policy stipulates that
committee membership be balanced in
terms of points of view represented, and
the committee’s function. Appointments
shall be made without discrimination
on the basis of age, race, ethnicity,
gender, sexual orientation, gender
identity, HIV status, disability, and
cultural, religious, or socioeconomic
status. Nominees must be U.S. citizens,
and cannot be full-time employees of
the U.S. Government. Current
participation on federal workgroups or
prior experience serving on a federal
advisory committee does not disqualify
a candidate; however, HHS policy is to
avoid excessive individual service on
advisory committees and multiple
committee memberships. Committee
members are Special Government
Employees (SGEs), requiring the filing
of financial disclosure reports at the
beginning and annually during their
terms. CDC reviews potential candidates
for HICPAC membership each year and
provides a slate of nominees for
consideration to the Secretary of HHS
for final selection. HHS notifies selected
candidates of their appointment near
the start of the term in July 2022, or as
soon as the HHS selection process is
completed. Please note that the need for
different expertise varies from year to
year and a candidate who is not selected
in one year may be reconsidered in a
subsequent year. Candidates should
submit the following items:
■ Current curriculum vitae,
including complete contact information
(telephone numbers, mailing address,
email address); and
■ At least one letter of
recommendation from person(s) not
employed by the U.S. Department of
Health and Human Services.
(Candidates may submit letter(s) from
current HHS employees if they wish,
but at least one letter must be submitted
by a person not employed by an HHS
agency (e.g., CDC, NIH, FDA, etc.).
Nominations may be submitted by the
candidate him- or herself, or by the
person/organization recommending the
candidate.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
SUPPLEMENTARY INFORMATION:
PO 00000
Frm 00057
Fmt 4703
Sfmt 4703
[FR Doc. 2021–05785 Filed 3–18–21; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–21–1238; Docket No. CDC–2021–
0029]
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies the opportunity to comment on
a proposed and/or continuing
information collection, as required by
the Paperwork Reduction Act of 1995.
This notice invites comment on a
proposed information collection project
titled, The EDN Tuberculosis Follow-Up
Worksheet for Newly-Arrived Persons
with Overseas Tuberculosis
Classifications. This TB follow-up
worksheet intends to capture domestic
TB examination data for persons
arriving to the U.S. with overseas TB
classifications.
DATES: CDC must receive written
comments on or before May 18, 2021.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2021–
0029 by any of the following methods:
• Federal eRulemaking Portal:
Regulations.gov. Follow the instructions
for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS–D74, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
Regulations.gov.
Please note: Submit all comments
through the Federal eRulemaking portal
(regulations.gov) or by U.S. mail to the
address listed above.
SUMMARY:
E:\FR\FM\19MRN1.SGM
19MRN1
14922
Federal Register / Vol. 86, No. 52 / Friday, March 19, 2021 / Notices
To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS–
D74, Atlanta, Georgia 30329; Telephone:
(404)639–7118. Email: omb@cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), Federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires Federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected; and
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses.
5. Assess information collection costs.
FOR FURTHER INFORMATION CONTACT:
jbell on DSKJLSW7X2PROD with NOTICES
Proposed Project
Information Collection for The EDN
Tuberculosis Follow-Up Worksheet for
VerDate Sep<11>2014
19:13 Mar 18, 2021
Jkt 253001
Newly-Arrived Persons with Overseas
Tuberculosis Classifications (OMB
Control No. 0920–1238, Exp. 6/30/
2021)—Revision—National Center for
Emerging and Zoonotic Infectious
Diseases (NCEZID), Centers for Disease
Control and Prevention (CDC).
Background and Brief Description
CDC highly recommends that persons
with overseas classification A or B for
TB receive U.S. follow-up evaluations to
prevent new transmission of TB. This
information will assist CDC in fulfilling
its regulatory responsibility to prevent
the importation and spread of
communicable diseases from foreign
countries (42 CFR part 71) and interstate
control of communicable diseases in
humans (42 CFR part 70). Section 361
of the Public Health Service (PHS) Act
(42 U.S.C. 264) authorizes the Secretary
of Health and Human Services to make
and enforce regulations necessary to
prevent the introduction, transmission,
or spread of communicable disease from
foreign countries into the United States.
Under its delegated authority in 42 CFR
parts 70 and 71, the Division of Global
Migration and Quarantine (DGMQ)
works to fulfill this responsibility
through numerous activities that
include monitoring the arrival of
persons with Class A and Class B
tuberculosis (TB) conditions and
coordinating domestic follow-up
examinations to prevent new
transmission of TB in the United States.
The Secretary of Health and Human
Services also has the legal authority to
establish regulations outlining the
requirements for the medical
examination of aliens before they may
be admitted into the United States. This
authority is provided under Section
212(a)(1)(A) of the Immigration and
Nationality Act (8 U.S.C. 1182(a)(1)(A))
and Section 325 of the Public Health
Service Act 42 U.S.C. 252. These
regulations are codified in 42 CFR part
34, which establish requirements that
determine whether aliens can be
admitted into the United States, which
includes health examinations when
aliens attempt to adjust status to lawful
permanent residents.
The TB follow-up worksheet is
designed to capture U.S. TB
examination data for newly arriving
PO 00000
Frm 00058
Fmt 4703
Sfmt 4703
persons to the U.S. with overseas
classification A and B for TB. The
information collected by the TB followup worksheet will provide a method of
performing several TB prevention
activities, both international and
domestic in nature.
The U.S. foreign-born population had
the highest incidence of TB compared to
the U.S. non-foreign-born population.
CDC strongly recommends incoming
persons receive follow-up examinations
for TB in the U.S. This data collection
will facilitate the methodical collection
of TB follow-up outcome data to
monitor and track persons with overseas
classification A and B for TB and will
assist in the national effort to prevent
new transmission of TB. To accurately
determine rates of TB, recent U.S.
arrivals receive domestic follow-up
evaluations. U.S. health departments
will provide domestic follow-up
outcome information to CDC. Without
this data, DGMQ will not have a method
of tracking and monitoring newly
arrived persons with overseas
classification A or B for TB. DGMQ will
use information reported on the
worksheet to ensure that TB programs
are effectively tracking new foreign
arrivals and coordinating follow-up
evaluations with local clinicians. To
monitor and evaluate domestic TB
program performance, CDC needs to
collect data on all elements of TB
domestic follow-up evaluations
including chest x-rays, diagnoses, and
U.S. treatment outcomes.
The Division of Global Migration and
Quarantine (DGMQ) staff along with
other federal partners will also use this
information to evaluate overseas panel
physician performance and overseas
prevention activities. To evaluate panel
physician performance and overseas TB
prevention activities, CDC needs to
know the results of domestic chest xrays (CXR), CXR comparison sputum
smears and cultures, and TB diagnoses
along with domestic reviews of overseas
treatment.
There are no costs to respondents
except their time to complete the
questionnaires. The annualized burden
for this data collection is 2,322 hours.
E:\FR\FM\19MRN1.SGM
19MRN1
14923
Federal Register / Vol. 86, No. 52 / Friday, March 19, 2021 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS
Average
burden per
response
(in hours)
Number of
responses per
respondent
Total burden
(in hours)
Form name
EDN data entry staff at state
and local health departments.
The EDN Tuberculosis Follow-Up Worksheet for Newly-Arrived Persons with
Overseas Tuberculosis Classifications.
1,548
3
30/60
2,322
.......................................................................
........................
........................
........................
2,322
Total ...............................
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2021–05762 Filed 3–18–21; 8:45 am]
BILLING CODE 4163–18–P
Prevention and the Agency for Toxic
Substances and Disease Registry.
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2021–05784 Filed 3–18–21; 8:45 am]
[FR Doc. 2021–05786 Filed 3–18–21; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
BILLING CODE 4163–18–P
Centers for Disease Control and
Prevention
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Healthcare Infection Control Practices
Advisory Committee (HICPAC);
Correction
Centers for Disease Control and
Prevention
Notice is hereby given of a change in
the meeting of the Healthcare Infection
Control Practices Advisory Committee
(HICPAC); March 4, 2021, 9:00 a.m. to
3:00 p.m., EST in the original FRN.
The teleconference was published in
the Federal Register on January 14,
2021, Volume 86, Number 9, pages
3155–3156.
The teleconference is being corrected
to update the meeting time and should
read as follows:
DATE: The meeting will be held on
March 4, 2021, from 1:00 p.m. to 3:00
p.m., EST.
KooWhang Chung, M.P.H., HICPAC,
Division of Healthcare Quality
Promotion, National Center for
Emerging Zoonotic Infectious Diseases,
CDC, 1600 Clifton Road NE, Mailstop
H16–3, Atlanta, Georgia 30329–4027,
telephone (404) 498–0730; HICPAC@
cdc.gov.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
FOR FURTHER INFORMATION CONTACT:
jbell on DSKJLSW7X2PROD with NOTICES
Number of
respondents
Type of respondents
VerDate Sep<11>2014
19:13 Mar 18, 2021
Jkt 253001
Interagency Committee on Smoking
and Health (ICSH); Notice of Charter
Renewal
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
AGENCY:
ACTION:
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Advisory Council for the Elimination of
Tuberculosis (ACET); Notice of Charter
Renewal
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
AGENCY:
ACTION:
Notice of charter renewal.
Notice of charter renewal.
This gives notice under the
Federal Advisory Committee Act of
October 6, 1972, that the Interagency
Committee on Smoking and Health
(ICSH), Centers for Disease Control and
Prevention, Department of Health and
Human Services, has been renewed for
a 2-year period through March 20, 2023.
This gives notice under the
Federal Advisory Committee Act of
October 6, 1972, that the Advisory
Council for the Elimination of
Tuberculosis (ACET), Centers for
Disease Control and Prevention,
Department of Health and Human
Services, has been renewed for a 2-year
period through March 15, 2023.
FOR FURTHER INFORMATION CONTACT:
FOR FURTHER INFORMATION CONTACT:
SUMMARY:
SUMMARY:
Kathryn Gallagher, Designated Federal
Officer, Interagency Committee on
Smoking and Health (ICSH), Centers for
Disease Control and Prevention,
Department of Health and Human
Services, 1600 Clifton Road NE,
Mailstop S107–7, Atlanta, Georgia
30329–4027, telephone (404) 639–6358;
KGallagher@cdc.gov.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
PO 00000
Frm 00059
Fmt 4703
Sfmt 4703
CAPT Deron Burton, M.D., J.D., M.P.H.,
Designed Federal Officer, Advisory
Council for the Elimination of
Tuberculosis (ACET), Centers for
Disease Control and Prevention,
Department of Health and Human
Services, 1600 Clifton Road NE,
Mailstop USB–6, Atlanta, Georgia
30329–4027, telephone (404) 639–1506;
DBurton@cdc.gov.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
E:\FR\FM\19MRN1.SGM
19MRN1
]]>Agencies
[Federal Register Volume 86, Number 52 (Friday, March 19, 2021)]
[Notices]
[Pages 14921-14923]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-05762]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-21-1238; Docket No. CDC-2021-0029]
Proposed Data Collection Submitted for Public Comment and
Recommendations
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice with comment period.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), as part
of its continuing effort to reduce public burden and maximize the
utility of government information, invites the general public and other
Federal agencies the opportunity to comment on a proposed and/or
continuing information collection, as required by the Paperwork
Reduction Act of 1995. This notice invites comment on a proposed
information collection project titled, The EDN Tuberculosis Follow-Up
Worksheet for Newly-Arrived Persons with Overseas Tuberculosis
Classifications. This TB follow-up worksheet intends to capture
domestic TB examination data for persons arriving to the U.S. with
overseas TB classifications.
DATES: CDC must receive written comments on or before May 18, 2021.
ADDRESSES: You may submit comments, identified by Docket No. CDC-2021-
0029 by any of the following methods:
Federal eRulemaking Portal: Regulations.gov. Follow the
instructions for submitting comments.
Mail: Jeffrey M. Zirger, Information Collection Review
Office, Centers for Disease Control and Prevention, 1600 Clifton Road
NE, MS-D74, Atlanta, Georgia 30329.
Instructions: All submissions received must include the agency name
and Docket Number. CDC will post, without change, all relevant comments
to Regulations.gov.
Please note: Submit all comments through the Federal eRulemaking
portal (regulations.gov) or by U.S. mail to the address listed above.
[[Page 14922]]
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the information collection plan
and instruments, contact Jeffrey M. Zirger, Information Collection
Review Office, Centers for Disease Control and Prevention, 1600 Clifton
Road NE, MS-D74, Atlanta, Georgia 30329; Telephone: (404)639-7118.
Email: [email protected]gov.
SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995
(PRA) (44 U.S.C. 3501-3520), Federal agencies must obtain approval from
the Office of Management and Budget (OMB) for each collection of
information they conduct or sponsor. In addition, the PRA also requires
Federal agencies to provide a 60-day notice in the Federal Register
concerning each proposed collection of information, including each new
proposed collection, each proposed extension of existing collection of
information, and each reinstatement of previously approved information
collection before submitting the collection to the OMB for approval. To
comply with this requirement, we are publishing this notice of a
proposed data collection as described below.
The OMB is particularly interested in comments that will help:
1. Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
2. Evaluate the accuracy of the agency's estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and clarity of the information to
be collected; and
4. Minimize the burden of the collection of information on those
who are to respond, including through the use of appropriate automated,
electronic, mechanical, or other technological collection techniques or
other forms of information technology, e.g., permitting electronic
submissions of responses.
5. Assess information collection costs.
Proposed Project
Information Collection for The EDN Tuberculosis Follow-Up Worksheet
for Newly-Arrived Persons with Overseas Tuberculosis Classifications
(OMB Control No. 0920-1238, Exp. 6/30/2021)--Revision--National Center
for Emerging and Zoonotic Infectious Diseases (NCEZID), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
CDC highly recommends that persons with overseas classification A
or B for TB receive U.S. follow-up evaluations to prevent new
transmission of TB. This information will assist CDC in fulfilling its
regulatory responsibility to prevent the importation and spread of
communicable diseases from foreign countries (42 CFR part 71) and
interstate control of communicable diseases in humans (42 CFR part 70).
Section 361 of the Public Health Service (PHS) Act (42 U.S.C. 264)
authorizes the Secretary of Health and Human Services to make and
enforce regulations necessary to prevent the introduction,
transmission, or spread of communicable disease from foreign countries
into the United States. Under its delegated authority in 42 CFR parts
70 and 71, the Division of Global Migration and Quarantine (DGMQ) works
to fulfill this responsibility through numerous activities that include
monitoring the arrival of persons with Class A and Class B tuberculosis
(TB) conditions and coordinating domestic follow-up examinations to
prevent new transmission of TB in the United States.
The Secretary of Health and Human Services also has the legal
authority to establish regulations outlining the requirements for the
medical examination of aliens before they may be admitted into the
United States. This authority is provided under Section 212(a)(1)(A) of
the Immigration and Nationality Act (8 U.S.C. 1182(a)(1)(A)) and
Section 325 of the Public Health Service Act 42 U.S.C. 252. These
regulations are codified in 42 CFR part 34, which establish
requirements that determine whether aliens can be admitted into the
United States, which includes health examinations when aliens attempt
to adjust status to lawful permanent residents.
The TB follow-up worksheet is designed to capture U.S. TB
examination data for newly arriving persons to the U.S. with overseas
classification A and B for TB. The information collected by the TB
follow-up worksheet will provide a method of performing several TB
prevention activities, both international and domestic in nature.
The U.S. foreign-born population had the highest incidence of TB
compared to the U.S. non-foreign-born population. CDC strongly
recommends incoming persons receive follow-up examinations for TB in
the U.S. This data collection will facilitate the methodical collection
of TB follow-up outcome data to monitor and track persons with overseas
classification A and B for TB and will assist in the national effort to
prevent new transmission of TB. To accurately determine rates of TB,
recent U.S. arrivals receive domestic follow-up evaluations. U.S.
health departments will provide domestic follow-up outcome information
to CDC. Without this data, DGMQ will not have a method of tracking and
monitoring newly arrived persons with overseas classification A or B
for TB. DGMQ will use information reported on the worksheet to ensure
that TB programs are effectively tracking new foreign arrivals and
coordinating follow-up evaluations with local clinicians. To monitor
and evaluate domestic TB program performance, CDC needs to collect data
on all elements of TB domestic follow-up evaluations including chest x-
rays, diagnoses, and U.S. treatment outcomes.
The Division of Global Migration and Quarantine (DGMQ) staff along
with other federal partners will also use this information to evaluate
overseas panel physician performance and overseas prevention
activities. To evaluate panel physician performance and overseas TB
prevention activities, CDC needs to know the results of domestic chest
x-rays (CXR), CXR comparison sputum smears and cultures, and TB
diagnoses along with domestic reviews of overseas treatment.
There are no costs to respondents except their time to complete the
questionnaires. The annualized burden for this data collection is 2,322
hours.
[[Page 14923]]
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average
Number of Number of burden per Total burden
Type of respondents Form name respondents responses per response (in (in hours)
respondent hours)
----------------------------------------------------------------------------------------------------------------
EDN data entry staff at state The EDN 1,548 3 30/60 2,322
and local health departments. Tuberculosis
Follow-Up
Worksheet for
Newly-Arrived
Persons with
Overseas
Tuberculosis
Classifications.
---------------------------------------------------------------
Total..................... ................ .............. .............. .............. 2,322
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2021-05762 Filed 3-18-21; 8:45 am]
BILLING CODE 4163-18-P
